{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:05:01Z","timestamp":1790222701580,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001186","name":"Australian Cystic Fibrosis Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002346-02"],"award-info":[{"award-number":["KL2TR002346-02"]}],"id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013347","name":"Institute of Translational Health Sciences, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011302","name":"Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcf.2019.08.025","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T04:55:10Z","timestamp":1572756910000},"page":"S25-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"S2","title":["Continuous glucose monitoring in cystic fibrosis \u2013 A practical guide"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-7672","authenticated-orcid":false,"given":"Christine L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Larson","family":"Ode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-6724","authenticated-orcid":false,"given":"Amir","family":"Moheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihab","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09674845.2012.12002443","article-title":"A history of blood glucose meters and their role in self-monitoring of diabetes mellitus","volume":"69","author":"Clarke","year":"2012","journal-title":"Br J Biomed Sci"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0010","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O'Riordan","year":"2009","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.025_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2004.01219.x","article-title":"Conventional measures underestimate glycaemia in cystic fibrosis patients","volume":"21","author":"Dobson","year":"2004","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/JPEM.2008.21.2.109","article-title":"Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis","volume":"21","author":"Franzese","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.025_bb0025","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.025_bb0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc10-2289","article-title":"Hyperglycemia and death in cystic fibrosis-related diabetes","volume":"34","author":"Adler","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.025_bb0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.025_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.025_bb0050","first-page":"860","article-title":"Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy","volume":"90","author":"Rolon","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2019.08.025_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2019.03.010","article-title":"Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis","author":"Prentice","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.025_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"International Society for P, adolescent D. ISPAD clinical practice consensus guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.025_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","article-title":"Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance","volume":"40","author":"Moreau","year":"2008","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.025_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcf.2014.06.004","article-title":"Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance","volume":"14","author":"Merjaneh","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.025_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2019.03.010","article-title":"Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis","author":"Prentice","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.025_bb0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.025_bb0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-1020","article-title":"Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system","volume":"162","author":"Schiaffini","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcf.2019.08.025_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200 mg\/dl during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","volume":"2016","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.025_bb0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOP.0000000000000251","article-title":"Advances in the detection and management of cystic fibrosis related diabetes","volume":"27","author":"Hameed","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jcf.2019.08.025_bb0110","series-title":"American Diabetes Association's 79th Scientific Session","article-title":"Continuous glucose monitoring and Beta-cell function in youth with cystic fibrosis","author":"Chan Cl","year":"2019"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.025_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.025_bb0120","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.025_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcf.2018.05.005","article-title":"Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes","volume":"17","author":"Frost","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.025_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/pedi.12470","article-title":"Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females","volume":"18","author":"Haliloglu","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.025_bb0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dia.2013.0051","article-title":"Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile (AGP)","volume":"15","author":"Bergenstal","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.025_bb0145","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.025_bb0150","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"9131","key":"10.1016\/j.jcf.2019.08.025_bb0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jcf.2019.08.025_bb0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes","year":"1993","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.025_bb0165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/00325481.2017.1383137","article-title":"Professional flash continuous glucose monitoring as a supplement to A1C in primary care","volume":"129","author":"Hirsch","year":"2017","journal-title":"Postgrad Med"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.025_bb0170","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/dc15-0099","article-title":"Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers!","volume":"38","author":"Bergenstal","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0175","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"Sacks","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.025_bb0180","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc17-2419","article-title":"Hemoglobin A1c accurately predicts continuous glucose monitoring-derived average glucose in youth and young adults with cystic fibrosis","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2019.08.025_bb0185","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc18-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes A. 6","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.025_bb0190","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized Trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00592-014-0643-6","article-title":"The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience","volume":"52","author":"Rachmiel","year":"2015","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.025_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/dc09-1502","article-title":"Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial","volume":"33","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G","year":"2010","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.jcf.2019.08.025_bb0210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.025_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/dia.2007.0238","article-title":"Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control","volume":"10","author":"Klupa","year":"2008","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.025_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.12158","article-title":"Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?","volume":"16","author":"Scheuing","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0225","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.025_bb0230","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/dc09-1971","article-title":"Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals","volume":"33","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.025_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.025_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/CS20030333","article-title":"Effect of hyperglycaemia on glucose concentration of human nasal secretions","volume":"106","author":"Wood","year":"2004","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.025_bb0245","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.025_bb0250","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1089\/dia.2017.0024","article-title":"Clinical use of continuous glucose monitoring in adults with type 2 Diabetes","volume":"19","author":"Carlson","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.025_bb0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2018.07.010","article-title":"Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor","volume":"18","author":"Li","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.025_bb0276","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.025_bb0277","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcf.2019.08.004","article-title":"Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment","volume":"18","author":"Moheet","year":"2019","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919931930880X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919931930880X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:59Z","timestamp":1761601319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919931930880X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":53,"alternative-id":["S156919931930880X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.025","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring in cystic fibrosis \u2013 A practical guide","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}